Pfizer Seeks Dismissal of Allele’s Patent Infringement Suit Over COVID-19 Vaccine Research Tool

Allele alleges Pfizer and BioNTech infringed patent on fluorescent protein used in vaccine trials; Pfizer warns litigation could hinder pandemic response efforts

IIPLA News Desk•anonymous access•0 articles left this week

Pfizer Seeks Dismissal of Allele’s Patent Infringement Suit Over COVID-19 Vaccine Research Tool

You have reached the guest article limit.

Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.

Allele Technologies has filed a patent infringement lawsuit against Pfizer and BioNTech, claiming unauthorized use of its patented fluorescent protein mNeonGreen in COVID-19 vaccine development. Pfizer has moved to dismiss the case, invoking the Hatch-Waxman safe harbor exemption and describing the litigation as a pot…

Share This Article

Ready-to-post copy includes the article link.

Pfizer Seeks Dismissal of Allele’s Patent Infringement Suit Over COVID-19 Vaccine Research Tool Allele Technologies has filed a patent infringement lawsuit against Pfizer and BioNTech, claiming unauthorized use of its patented fluorescent protein mNeonGreen in COVID-19 vaccine development. Pfizer has moved to dism... Read the full IIPLA article: https://iipla.org/news/pfizer-seeks-dismissal-of-allele-s-patent-infringement-suit-over-covid-19-vaccine-research-tool

LinkedIn X Facebook WhatsApp Telegram Email

Related Coverage

Continue in the newsroom

Back to newsroom

LitigationSoutheast Asia

Vietnamese Press Faces Rising Challenges in Copyright Protection Amid AI and Social Media Growth

The rapid expansion of artificial intelligence and social networks in Vietnam has intensified copyright infringement issues for press agencies. Legal professionals emphasize the necessity for press organizations to adopt comprehensive copyright management strategies, enforce legal actions against violators, and uphold…

Sunday, June 21, 2026

LitigationGlobal

UK Litigation Update Puts Bigger and LatestAICareersCopyrightCommunity Strategy in Focus

IIPLA reviews the litigation implications of Litigation, Bigger, LatestAICareersCopyrightCommunity, with practical notes for UK IP teams monitoring risk, enforcement, licensing, and portfolio strategy.

Friday, June 19, 2026

PatentsUSA

Maryland Exercises Right of First Refusal to Acquire Preakness Stakes Intellectual Property, Blocking Churchill Downs’ $85M Bid

Maryland has invoked its statutory right of first refusal to purchase the intellectual property rights of the Preakness Stakes and Black-Eyed Susan Stakes from 1/ST Maryland LLC. This move effectively halts Churchill Downs’ $85 million offer made in April to acquire the IP. Governor Wes Moore emphasized the importance…

Thursday, June 18, 2026

TrademarksUSA

Maryland State to Acquire Preakness Stakes Intellectual Property, Ensuring Long-Term Control of Iconic Horse Racing Event

The State of Maryland has declared its intent to exercise its right of first refusal to purchase the intellectual property rights to the Preakness Stakes and Black-Eyed Susan from Churchill Downs, Inc. This strategic acquisition, funded through tax-exempt bonds without using General Fund dollars, consolidates Maryland…

Thursday, June 18, 2026

PatentsUSA

Maryland Allocates $85 Million to Acquire Preakness Stakes and Black-Eyed Susan IP Rights

Maryland is investing $85 million to obtain intellectual property rights for the Preakness Stakes and Black-Eyed Susan, matching a prior bid from Churchill Downs. The acquisition, funded through a tax-exempt bond, aims to protect the state's horseracing legacy and reduce future licensing costs.

Thursday, June 18, 2026

PatentsUSA

Maryland Exercises Right to Match $85 Million Offer for Preakness Stakes Intellectual Property

Maryland has announced its intent to match an $85 million bid by Churchill Downs Inc. to acquire the intellectual property rights of the Preakness Stakes and Black-Eyed Susan Stakes. By exercising its right of first refusal, Maryland aims to retain ownership of these iconic racing assets, ensuring long-term control ov…

Thursday, June 18, 2026